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LETTERS-TO-THE-EDITOR
Regarding “Glomerular filtration rate after left renal
vein division and reconstruction during infrarenal
aortic aneurysm repair”
We read with great interest the article by Marrocco-Trischitta
et al1 and would like to offer some comments. This article is
particularly important in the present climate of endovascular aneu-
rysm repair (EVAR). In our unit, fenestrated EVAR devices are not
currently popular and therefore juxta-renal aneurysms tend to be
repaired by open surgery. Although the article indicates that only
1.3% of the patients undergoing open AAA repair required left
renal vein (LRV) division, we believe that the need to divide the
LRV during open abdominal aortic aneurysm (AAA) repair is likely
to rise in the future. Hence, it is important to know whether
reconstruction of the LRV is truly necessary.
The article concludes that reconstruction of the left renal vein
(LRV) following its division during open repair of infrarenal ab-
dominal aortic aneurysms (AAA) restores preoperative renal func-
tional status without increasing the complication rate or total
operative time. In the absence of a control group (ie, LRV divided
during surgery but not reconstructed), it is erroneous to conclude
that the restoration of renal function was due to LRV reconstruc-
tion. In our experience, LRV division has not lead to a profound
deterioration of renal function postoperatively as shown in our
paper published in 2000.2 We accept that calculated glomerular
filtration rate (GFR) may be a more sensitive marker of renal
dysfunction than serum creatinine and are in the process of repeat-
ing our audit of LRV division during AAA surgery using this tool.
Only patients undergoing elective AAA repair were included
in the study. The need to divide the LRV may be more crucial in
emergency repair of AAA. In these unstable patients, LRV recon-
struction may add to the operative time and may increase morbid-
ity. Therefore, the results should not be extended to emergency
patients undergoing AAA repair, and these patients need to be
studied independently.
Our practice is to divide the LRV beyond (to the right of) the
union of the left suprarenal, left gonadal, and left lumbar renal veins
therebymaintaining some collateral circulation.We believe that this is
sufficient to preserve the venous return from the left kidney and
restore renal function over time. Another important factor in deter-
mining postoperative renal function is renal thrash (ie, microemboli)
due to the juxta-renal position of the aortic clamp.
These and several other factors need to be addressed before LRV
reconstruction can be recommended as a safe, effective, and necessary
step in open repair of AAA. A well-designed randomized controlled
trial in emergency and elective patients is the way forward.
Tapan Anil Mehta, MBBS, FRCS
James M. Clarke, MS FRCS
Department of Vascular Surgery
Norfolk and Norwich University Hospital
Norwich, United Kingdom
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Reply
The interest of Dr Elsharawy and coworkers for our article is
much appreciated. Indeed, we believe that our conclusions, rather
than erroneous, were based on straightforward results. We showed
that left renal vein (LRV) reconstruction after its division: (1) is
feasible without significantly lengthening operative time; (2) is not
associated with increased complication rates; (3) is not associated
with renal derangements since glomerular filtration rate remained
unchanged as in patients in whom the LRV was left intact; and (4)
appears to be durable. We did not address nor draw conclusions
regarding the risks of LRV ligation that others have previously
reported. Hence, a control group of patients in whom the LRVwas
divided but not reconstructed was not necessary. We showed that
LRV reconstruction is safe and viable and therefore should not be
regarded as cumbersome.
We agree that our results were obtained in an elective setting
and therefore can not be extended to emergent abdominal aortic
aneurysm repair. Yet, the fact that LRV reconstruction may in-
crease perioperative morbidity is to be demonstrated. One can
argue that it may not be necessary in all cases, but the occurrence of
renal venous hypertension seems unpredictable, and we find it
unnecessary to take the chance.
In conclusion, our study showed that the reconstitution of
LRV anatomic continuity is safe and re-establishes a physiologic
condition. Advocates of LRV ligation have the burden of the
evidence to prove their case.
Massimiliano M. Marrocco-Trischitta, MD
Germano Melissano, MD
Roberto Chiesa, MD
Vascular Surgery, San Raffaele Scientific Institute
Milan, Italy
doi:10.1016/j.jvs.2007.07.031
Regarding “Endovenous laser treatment of the short
saphenous vein: Efficacy and complications”
Although Gibson and associates have addressed an infre-
quently discussed subject—the small saphenous vein (SSV; not the
short saphenous vein)—the article has omitted some important
details.1 This article did not adequately incorporate the Venous
Reporting Standards, current anatomic terminology, or a valid
outcome assessment, such as the Venous Severity Score. Outdated
references to the “short” saphenous vein or “Giacomini vein”
should no longer be used.2 What they call the “CEAP classifica-
tion” is only the C portion. There is no information on E (etiol-
ogy) or A (anatomy). For P (physiology), obstruction was ex-
cluded, so that I presume all limbs had reflux.3
The absence of Venous Severity Scores, particularly the Ve-
nous Clinical Severity Score, limits the assessment of this therapy’s
efficacy. These disease specific-outcome measures were developed
to assess the utility of interventions in patients with chronic venous
insufficiency,4 while in this article we are left with only surrogate
outcomes. Moreover, because the majority of patients had con-
comitant procedures to the great saphenous or perforating veins,
the specific effect of SSV treatment is blurred.
Important details of diagnostic techniques and their criteria are
absent, such as (1) the criteria for SSV reflux and the mean/median
valve closure time, and (2) the criteria for perforator incompetence—
reflux/diameter, or both. Because nearly 70% of the study population
was class II and 136 limbs underwent perforator ligation, many of
these perforators were in either class II or III. This is a relatively high
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number of perforating veins to be found and treated in these “mild”
classes. Were they really just branch veins?
The authors provide no information on where they accessed
the SSV and how much was ablated, a point of debate in en-
dovenous SSV treatment. The observation regarding the frequent
relationship of the SSV to the intersaphenous vein, either as an
extension or a direct continuation in 57% of the limbs, is a unique
anatomic finding. I am curious, however, why no other incompe-
tent veins of the popliteal fossa, such as the gastrocnemius or
popliteal area veins, which are not accessible to their technique,
were not detected in such a large series. These other veins of the
popliteal fossa may, if incompetent, perpetuate reflux in the pop-
liteal fossa, even if the SSV is treated properly. For example, Gillet
et al5 reported a 20% incidence of incompetent gastrocnemius
veins in a series of 180 operations for SSV incompetence, a pro-
portion similar to that described by Hobbs and Vandendriessche.6
The 5.7% incidence of deep venous thrombosis is troubling,
particularly when compared with results with endovenous laser
treatment of the great saphenous vein or open surgical series.
Moreover, the incidence is actually higher in this series, when the
patients with type C anatomy (no direct termination of the SSV in
the popliteal vein) are eliminated. In these patients there is no
chance of thermal energy from the laser tip directly damaging the
popliteal vein. When the incidence of deep vein thrombosis is
calculated on this basis, the incidence for at risk patients was
actually 12%. This may be too high a price to pay for this less
invasive approach to the SSV.
Thomas F. O’Donnell, Jr, MD
The Vein Center
Tufts-New England Medical Center
Boston, Mass
REFERENCES
1. Gibson KD, Ferris BL, Polissar N, Neradilek B, Pepper D. Endovenous
laser treatment of the short saphenous vein: efficacy and complications. J
Vasc Surg 2007;45:795-803.
2. Cagiatti A, Bergan JJ, Gloviczki P, Eklof B, Allegra C, Partsch H, et al.
Nomenclature of the veins of the lower limb: Extensions, refinements,
and clinical applications. J Vasc Surg 2005;41:719-24.
3. Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner
RI, et al. American Venous Forum International Ad Hoc Committee for
Revision of the CEAP Classification for Chronic Venous Disorders:
consensus statement. J Vasc Surg 2004;40:1248-52.
4. Rutherford RB, Padberg FT, Comerata AJ, Meissner MH, Moneta GL.
American Venous Forum’s Ad Hoc Committee on Venous Outcomes
Assessment. Venous Severity Scoring: an adjunct to venous outcome
assessment. J Vasc Surg 2000;31:1307-12.
5. Gillet JL, PerrinM, Hiltbrand B, Bayon JM, Gobin JP, Calvinac JL, et al.
Pre- and postoperative contribution of Doppler sonography in superficial
venous surgery of the popliteal fossa. J Mal Vasc 1997;22:330-5.
6. Hobbs JT, Vandendriessche MW. Incompetence of the gastrocnemius
vein. Phlebology 2004;19:57-64.
doi:10.1016/j.jvs.2007.06.053
Reply
We thankDrO’Donnell for his comments and agree that report-
ing standards and current anatomic terminology are important. The
paper was submitted as “Endovenous Laser Treatment of the Small
Saphenous Vein: Efficacy and Complications,” but the anatomic
terminology was changed by the JVS proofreaders in error to “short
saphenous vein.” A correction has been issued by JVS.
The purpose of our series was to show that EVLT of the small
saphenous vein (SSV) was feasible and to determine the rate of
complications. We defined efficacy as duplex-proven closure of the
SSV and elimination of reflux. DrO’Donnell alludes in his comments
to the reason that we did not include the Venous Clinical Severity
Score as a measure of efficacy. Because fully 78% of limbs underwent
concomitant EVLT of the great saphenous vein, it would be impos-
sible to tease out what the benefit of the SSV ablation was specifically
in terms of any change in the Venous Clinical Severity Score. Instead,
we defined efficacy very objectively, as stated above.
Dr O’Donnell is correct in noting that only the CEAP clinical
classification is noted in the article. In the article and the accom-
panying table, we did call this “CEAP clinical classification” and
not just “CEAP classification.” Dr O’Donnell is also correct in
assuming that all limbs had reflux.
Because the paper had to be edited to meet the length require-
ments of JVS, a number of procedural details and details regarding
concomitant procedures (great saphenous vein EVLT, perforator
ligation, and microphlebectomy) were not outlined. In our vascular
laboratory, we define reflux by valve closure time greater than
2 seconds.Mean andmedian valve closure times were not collected in
the data for the study. SSVs were treated only if they demonstrated
reflux and were causing clinical symptoms or were cosmetically both-
ersome varicose veins. Criteria for perforator incompetence included
both reflux anddiameter. Perforator veinswere treatedonly if deemed
to be either clinically or cosmetically significant: ie, if they were
tributaries into clusters of varicosities that either were symptomatic or
bothered the patient from a cosmetic standpoint. Although other
authors have found that routine perforator ligation is unnecessary in
treating patients without deep venous insufficiency in terms of im-
provement in APG-measured hemodynamic parameters and clinical
symptom score,1 in our practice we have had suboptimal cosmetic
results when we have left perforator veins to clusters of varicosities
remote from the SSV or great saphenous vein untreated.
The length of SSV treated and the access point were left to the
discretion of the treating surgeon (three surgeons were involved in
the study). In general, the ablation was started 1.5 to 2.0 cm from
the saphenopopliteal junction (SPJ) if no intersaphenous vein was
present and just distal to the intersaphenous vein if it was present.
Access was obtained in some cases as low as just above the lateral
malleolus. We noted no difference in the incidence of paresthesias
in patients with “low” access. Incompetent popliteal fossa veins
other than the intersaphenous vein were not specifically tracked,
but if present and causing clusters of varicosities untreated by
EVLT, they were addressed by microphlebectomy of the branches.
We agree that a 5.7% incidence of deep venous thrombosis
(DVT) is high (the incidence was 11.4% for type A anatomy, 2.9% for
type B anatomy, and 0% for type C anatomy); however, we believe
that our definition of DVT was very conservative. Any extension of
clot into the SPJ was defined as aDVT.Wewould now describe these
clots as endovenous heat-induced thrombosis (EHIT; as described by
Kabnick et al2).We agreewithKabnick and colleagues that EHITs do
not behave like de novo DVTs. Kabnick and associates’ abstract
suggested that clots flush with the saphenofemoral junction or SPJ
do not need anticoagulation and recommended that clots extend-
ing into the saphenofemoral junction or SPJ filling less than 50% of
the diameter of the deep vein be treated with low-molecular-
weight heparin until the thrombus recedes out of the deep vein.
Clots filling greater than 50% of the diameter of the deep vein or
occlusive clots are treated with standard DVT treatments. Accord-
ing to these criteria, none of the limbs in our study with “DVT”
would require standardDVT treatment, as all filled less than 50% of
the popliteal lumen. Since completing this study, we treat our
patients with EHIT with the above algorithm, and all have uni-
formly showed resolution of the EHIT within a matter of days
without any bleeding or thrombotic complication. We believe that
EVLT of the SSV offers patients a significantly easier recovery with
reduced morbidity compared with stripping of the SSV. As EHITs
have had a benign course in all of our patients both during and
since our study and as the incidence of nerve injury is very low,
EVLT of the SSV is the procedure of choice in patients with SSV
incompetence in our practice.
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